Advertisement

 

 

Impact of genetic variations in C-C chemokine receptors and ligands on infectious diseases.

Author Information (click to view)

Qidwai T, Khan MY,


Qidwai T, Khan MY, (click to view)

Qidwai T, Khan MY,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Human immunology 2016 6 14() pii 10.1016/j.humimm.2016.06.010

Abstract

Chemokine receptors and ligands are crucial for extensive immune response against infectious diseases such as malaria, leishmaniasis, HIV and tuberculosis and a wide variety of other diseases. Role of chemokines are evidenced in the activation and regulation of immune cell migration which is important for immune response against diseases. Outcome of disease is determined by complex interaction among pathogen, host genetic variability and surrounding milieu. Variation in expression or function of chemokines caused by genetic polymorphisms could be associated with attenuated immune responses. Exploration of chemokine genetic polymorphisms in therapeutic response, gene regulation and disease outcome is important. Infectious agents in human host alter the expression of chemokines via epigenetic alterations and thus contribute to disease pathogenesis. Although some fragmentary data are available on chemokine genetic variations and their contribution in diseases, no unequivocal conclusion has been arrived as yet. We therefore, aim to investigate the association of CCR5-CCL5 and CCR2-CCL2 genetic polymorphisms with different infectious diseases, transcriptional regulation of gene, disease severity and response to therapy. Furthermore, the role of epigenetics in genes related to chemokines and infectious disease are also discussed.

Submit a Comment

Your email address will not be published. Required fields are marked *

three + 7 =

[ HIDE/SHOW ]